Journal
NATURE GENETICS
Volume 46, Issue 5, Pages 438-443Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2931
Keywords
-
Categories
Funding
- Jewish General Hospital Foundation
- Jodi Taiger Lazarus Fund
- Fonds de Recherche du Quebec-Sante
- KinderKrebsInitiative Buchholz/Holm-Seppensen
- Interdisziplinaren Zentrum fur Klinische Forschung (IZKF) Munster [Ha3/016/11]
Ask authors/readers for more resources
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is the most common undifferentiated ovarian malignancy in women under 40 years of age(1). We sequenced the exomes of six individuals from three families with SCCOHT. After discovering segregating deleterious germline mutations in SMARCA4 in all three families, we tested DNA from a fourth affected family, which also carried a segregating SMARCA4 germline mutation. All the familial tumors sequenced harbored either a somatic mutation or loss of the wild-type allele. Immunohistochemical analysis of these cases and additional familial and non-familial cases showed loss of SMARCA4 (BRG1) protein in 38 of 40 tumors overall. Sequencing of cases with available DNA identified at least one germline or somatic deleterious SMARCA4 mutation in 30 01 32 cases. Additionally, the SCCOHT cell line BIN-67 had biallelic deleterious mutations in SMARCA4. Our findings identify alterations in SMARCA4 as the major cause of SCCOHT, which could lead to improvements in genetic counseling and new treatment approaches.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available